Delivery Order SPE2DB22D9239-SPE2DB24FDL72

Award Date 8/15/24
Potential Completion Date 9/6/24
Potential Value $80K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $120,428.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 that the DLA has with DMS Pharmaceutical Group to provide a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. This delivery order is for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $48,131.04, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials by May 9, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $40,142.85 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract provides the Keytruda 100 mg/4 ml vial medication, with a period of performance running through May 14, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $98,274.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract covers the supply of Keytruda 100 mg/4 ml vials, a specialty oncology medication, to support the recurring medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $32,087.36, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda, a cancer immunotherapy drug, with a completion date of May 28, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a $16,057.14 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide...
The U.S. Defense Logistics Agency (DLA) has awarded a $77,505.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,560,580,827 units of Keytruda 100 mg/4 ml vial, a cancer medication, with a performance period ending on May 3, 2023. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is not set-aside, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 mL vials with a completion date of June 6, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, that enables the agency to issue delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $80,285.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,563,942,392 units of the drug Keytruda (100 mg/4 mL vial) to support the medical supply needs of military health facilities. This order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA,...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDL72
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials, a specialized oncology medication, with a period of performance through September 6, 2024.

This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's position as a prime vendor for pharmaceutical products to the Department of Defense (DoD) and Department of Veterans Affairs (VA) solidifies its role as a crucial supplier in the federal pharmaceutical supply chain.

Generated 11/14/24, 9:11 AM